InspireMD Inc - Asset Resilience Ratio
InspireMD Inc (NSPR) has an Asset Resilience Ratio of 34.21% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of InspireMD Inc to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2011–2025)
This chart shows how InspireMD Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see NSPR total assets.
Liquid Assets Composition Over Time
This chart breaks down InspireMD Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read NSPR liabilities breakdown for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $15.27 Million | 34.21% |
| Total Liquid Assets | $15.27 Million | 34.21% |
Asset Resilience Insights
- Very High Liquidity: InspireMD Inc maintains exceptional liquid asset reserves at 34.21% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
InspireMD Inc Industry Peers by Asset Resilience Ratio
Compare InspireMD Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medtronic plc
SA:MDTC34 |
Medical Devices | 7.82% |
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Biosynex
PA:ALBIO |
Medical Devices | 3.35% |
Annual Asset Resilience Ratio for InspireMD Inc (2011–2025)
The table below shows the annual Asset Resilience Ratio data for InspireMD Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 65.23% | $45.27 Million | $69.40 Million | +31.64pp |
| 2024-12-31 | 33.59% | $15.72 Million | $46.81 Million | -28.09pp |
| 2023-12-31 | 61.67% | $29.38 Million | $47.64 Million | +8.25pp |
| 2022-12-31 | 53.43% | $13.17 Million | $24.65 Million | -2.06pp |
| 2021-12-31 | 55.49% | $22.04 Million | $39.71 Million | -- |
| 2020-12-31 | 0.00% | $0.00 | $17.78 Million | -- |
| 2017-12-31 | 0.00% | $0.00 | $6.11 Million | -- |
| 2016-12-31 | 0.00% | $0.00 | $9.41 Million | -- |
| 2015-12-31 | 0.00% | $0.00 | $5.78 Million | -- |
| 2014-12-31 | 0.00% | $0.00 | $11.46 Million | -- |
| 2012-12-31 | 0.58% | $93.00K | $16.01 Million | +0.35pp |
| 2012-06-30 | 0.23% | $37.00K | $16.01 Million | -0.34pp |
| 2011-12-31 | 0.57% | $91.00K | $16.01 Million | -- |
About InspireMD Inc
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard c… Read more